Synopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies…
supply
-
-
AgrochemicalsCovid Drugs
Placebo effect accounts for more than two-thirds of COVID-19 vaccine adverse events
by adminby adminSynopsis : The placebo effect is the well-known phenomenon of a person’s physical or mental health improving after taking a treatment with…
-
Pharma Science & Research
Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against Omicron Variant
by adminby adminSynopsis : Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active…
-
IndiaPharma Science & Research
COVID-19: India supplies 5 lakh more Covaxin doses to Afghanistan
by adminby adminSynopsis: Bharat Biotech on Monday informed that India has supplied another batch of humanitarian assistance consisting of 5,00,000 doses of COVID-19 vaccine,…
-
AgrochemicalsIndia
Serum Institute CEO Hails WHO’s Approval of Covovax for Emergency Use
by adminby adminSynopsis- India-made Covovax on Friday became the ninth Covid-19 vaccine to receive WHO’s emergency use listing approval, with manufacturer Serum Institute of…
-
AgrochemicalsGlobal Market
Fujifilm to Expand US Biologics Manufacturing Capacity with $300M Texas outlay
by adminby adminSynopsis: In June, globe-trotting contract manufacturer Fujifilm Diosynth Biotechnologies unveiled an $850 million outlay to boost biologics capacity in the U.S. and…
-
Synopsis: Two districts, Mokokchung and Tuensang, were chosen for studying the feasibility of drone technology in delivery of medical supplies in Nagaland.…
-
AstraZenecaIndia
AstraZeneca is in Contact with Indian Authorities to have Evusheld Approved.
by adminby adminSummary : The company also said studies are underway to provide information on the impact of the new Omicron variant on Evusheld,…
-
Summary : The Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that…
-
IndiaPharma Science & Research
The NTAGI is Considering Giving Immunocompromised Persons a “Additional” Dosage of COVID-19 Vaccination.
by adminby adminSynopsis: A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is…